LAPTM4B-35 expression was significantly higher in the higher PCa stage and seminal vesicle invasion cases; LAPTM4B-35 expression was also significantly increased in PCa patients with lymph node metastasis, higher preoperative PSA, higher Gleason score, and BCR. The gene discussed is BCR; the disease is metastatic malignant neoplasm in the lymph nodes.